PKBO — Peak Bio Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.52m
- $9.33m
- $0.37m
Annual cashflow statement for Peak Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -13.3 | -8.29 | -13.1 | -12.8 |
| Depreciation | ||||
| Non-Cash Items | 1.03 | -0.841 | 3.08 | 1.75 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.519 | 0.093 | 2.37 | 6.17 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -11.6 | -8.86 | -7.49 | -4.76 |
| Capital Expenditures | -0.341 | -0.01 | -0.142 | 0 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -0.341 | -0.01 | -0.142 | 0 |
| Financing Cash Flow Items | 12.3 | 6.39 | 1.36 | -0.29 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 12.7 | 8.38 | 8.14 | 4.28 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.239 | 0.033 | 0.452 | -0.453 |